Inimmune to Showcase Pipeline Advances at World Vaccine Congress 2026
Missoula, MT — March 29, 2026 — Inimmune, a biotechnology company advancing next-generation vaccine adjuvants and immunotherapies, today announced that its leadership team will present new data and insights at the World Vaccine Congress (WVC) in Washington, DC, from March 30 to April 2, 2026. CEO David Burkhart, Ph.D., will chair the “Vaccine Technology Workshop” […]
